Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 358 participants.
Also called NCT04948749
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 358 participants
- Sponsor
- Registry
-
NCT04948749
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT04948749. Randomized; single masking; primary purpose treatment. Start 2021-07-02 (actual); primary completion 2027-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial
- Acronym
- DREAM-PRIDE
- Condition
- ICAD - Intracranial Atherosclerotic Disease
- Condition
- ICAS - Intracranial Atherosclerosis
- Condition
- Drug-eluting Stent
- Condition
- Stroke
- Condition
- Drug Eluting Stents (DES)
- Condition
- Medical Treatment
- Intervention (Device)
- Drug Eluting Stent implantation
- Intervention (Drug)
- Aggressive medical treatment
- Intervention (Behavioral)
- Risk factor management
- Intervention (Drug)
- Standard medical treatment
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct04948749- Content hash
b5af00fbe14e000cc55c86b5acb7add87f8da7a4c20b2bd207c94eee5b8d33d8